BIOMAT Database Logo BIOMAT Database Logo

Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors. 2016

Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga

This manuscript describes a novel class of N-acylhydrazone (NAH) derivatives that act as histone deacetylase (HDAC) 6/8 dual inhibitors and were designed from the structure of trichostatin A (1). Para-substituted phenyl-hydroxamic acids presented a more potent inhibition of HDAC6/8 than their meta analogs. In addition, the effect of compounds (E)-4-((2-(4-(dimethylamino)benzoyl)hydrazono)methyl)-N-hydroxybenzamide (3c) and (E)-4-((2-(4-(dimethylamino)benzoyl)-2-methylhydrazono)methyl)-N-hydroxybenzamide (3f) on the acetylation of α-tubulin revealed an increased level of acetylation. These two compounds also affected cell migration, indicating their inhibition of HDAC6. An analysis of the antiproliferative activity of these compounds, which presented the most potent activity, showed that compound 3c induced cell cycle arrest and 3g induced apoptosis through caspase 3/7 activation. These results suggest HDAC6/8 as a potential target of future molecular therapies for cancer.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006655 Histone Deacetylases Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes. Class I Histone Deacetylases,Class II Histone Deacetylases,HDAC Proteins,Histone Deacetylase,Histone Deacetylase Complexes,Complexes, Histone Deacetylase,Deacetylase Complexes, Histone,Deacetylase, Histone,Deacetylases, Histone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000073864 Histone Deacetylase 6 A class II histone deacetylase that removes acetyl groups from N-terminal LYSINES of HISTONE H2A; HISTONE H2B; HISTONE H3; and HISTONE H4. It plays a critical role in EPIGENETIC REPRESSION and regulation of GENETIC TRANSCRIPTION, as well as CELL MOTILITY through deacetylation of TUBULIN. It also targets misfolded proteins for clearance by AUTOPHAGY when MOLECULAR CHAPERONE-mediated folding is overwhelmed.
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations

Related Publications

Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Design, synthesis and biological evaluation of novel isoindolinone derivatives as potent histone deacetylase inhibitors.
April 2019, European journal of medicinal chemistry,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Design, Synthesis, and Biological Evaluation of Novel Acylhydrazone Derivatives as Potent Neuraminidase Inhibitors.
September 2020, ACS medicinal chemistry letters,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Design, synthesis, and cytotoxicity evaluation of novel indole-acylhydrazone derivatives of 4-pyridinone as potential histone deacetylase-2 inhibitors.
October 2022, Research in pharmaceutical sciences,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors.
May 2015, European journal of medicinal chemistry,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Synthesis and biological evaluation of novel N-benzyltriazolyl-hydroxamate derivatives as selective histone deacetylase 6 inhibitors.
February 2023, Bioorganic & medicinal chemistry,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity.
February 2020, European journal of medicinal chemistry,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: synthesis and antiproliferative evaluation.
November 2003, Current medicinal chemistry,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Design, Synthesis, and Pharmacological Evaluation of First-in-Class Multitarget N-Acylhydrazone Derivatives as Selective HDAC6/8 and PI3Kα Inhibitors.
March 2020, ChemMedChem,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
July 2019, European journal of medicinal chemistry,
Daniel A Rodrigues, and Guilherme À Ferreira-Silva, and Ana C S Ferreira, and Renan A Fernandes, and Jolie K Kwee, and Carlos M R Sant'Anna, and Marisa Ionta, and Carlos A M Fraga
Design, synthesis and biological evaluation of isoquinoline-based derivatives as novel histone deacetylase inhibitors.
September 2015, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!